Followers | 246 |
Posts | 49547 |
Boards Moderated | 70 |
Alias Born | 08/29/2007 |
Saturday, May 07, 2022 1:17:07 PM
Maybe BTTX is next. Not much out there in the way of hysteria plays for low priced tickers.
According to the profile, the company is in the business of behavior modification for diabetics. I am not an expert on this, but I figure there is plenty of competition in the healthcare business that focuses on behavior modification.
Diabetes in the US is certainly widespread within the population. One could even characterize it as an epidemic in its own right.
We will see if the size of the herd wanting in increases next week.
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent BTTX News
- Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq • Business Wire • 03/14/2024 01:38:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 01:01:07 PM
- Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers • Business Wire • 03/05/2024 02:25:00 PM
- Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) • Business Wire • 03/04/2024 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 01:51:02 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/01/2024 11:08:59 AM
- Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease • Business Wire • 02/20/2024 02:25:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 09:28:28 PM
- Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment • Business Wire • 02/06/2024 02:43:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:02:40 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:30:59 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/23/2024 10:22:26 PM
- Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone • Business Wire • 01/17/2024 02:28:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/10/2024 12:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:42:54 PM
- Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States • Business Wire • 01/04/2024 07:00:00 PM
- Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease • Business Wire • 01/02/2024 12:45:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/29/2023 02:23:11 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:21:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:23:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:21:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:10:07 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/13/2023 10:24:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:06:53 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM